Stable Coronary Artery Disease
Stable coronary artery disease (CAD) is a condition where the coronary arteries are narrowed or blocked, leading to reduced blood flow to the heart, often causing chest pain or discomfort during physical activity.
We are studying whether a genetic test-guided treatment improves blood platelet function in patients with stable coronary artery disease undergoing stenting. This may help determine the best anti-platelet therapy for individual patients.
Health conditions and diseases that the clinical trial is designed to study and treat.
Stable coronary artery disease (CAD) is a condition where the coronary arteries are narrowed or blocked, leading to reduced blood flow to the heart, often causing chest pain or discomfort during physical activity.
Chronic coronary syndrome refers to a long-term condition where the heart does not receive enough blood due to narrowed coronary arteries, leading to symptoms like chest pain and shortness of breath, especially during exertion.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.